Stephen Duckworth is a graduate in Applied Chemistry with over 30 years spent in the polymers and compounding industries in R&D, marketing and operations functions in the US, Europe and Asia, with leading international companies such as Raychem, General Electric (now SABIC), DSM, PolyOne and also as an independent consultant for market analysis, M&A, and Asia entry strategies. He joined Clariant in 2007 and left the company in 2020.
In 2008, Mr Duckworth initiated and led a global project to address the medical, pharmaceutical and healthcare sector that radically changed how Clariant approached this market, and the creation of a new brand MEVOPUR. In January 2011, he became the head of a newly formed segment focused on Healthcare, and led a team of dedicated specialists based in the US, Europe and Asia, which initiated and managed developments with pharmaceutical and medical devices companies and their supply chain in areas such as drug packaging and delivery devices, IVD, and invasive devices, focused around an approach of minimisation and management of risk of changes.
Mr Duckworth is President and Executive Board Member of the cross-industry group MedPharmPlast Europe, and member of the regulatory affairs committee of this association. MedPharmPlast monitors and analyses potential legislation and provides expert insights to the European Commission / legislators, and to the membership.